Article Details
Retrieved on: 2022-09-04 10:35:05
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Additionally, when the team tested the monoclonal antibodies casirivimab and imdevimab (known commercially as REGEN-Cov), they found that the ...
Article found on: scitechdaily.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here